Business Context and Reporting Period
Company: Acadia Healthcare Company, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 29, 2018
Event: Entry into a Material Definitive Agreement (Third Refinancing Facilities Amendment).
Key Financial Metrics and Debt Structure
This filing details a refinancing of the Company's credit facilities rather than reporting operational financial results (revenue, profit, or cash flow). Key debt metrics disclosed include:
- Revolving Facility: Line of credit remains at $500.0 million.
- Tranche A Term Loan: Reduced from $400.0 million to $380.0 million to reflect current outstanding principal.
- Interest Rate Structure: The Amendment modifies the "Applicable Rate" based on the Consolidated Leverage Ratio, establishing five pricing tiers ranging from a leverage ratio of less than 3.50:1.0 to greater than 5.25:1.0.
Note: The filing text does not provide clear values for revenue, net income, operating cash flow, or current liquidity positions beyond the credit facility limits.
Material Changes Versus Prior Period
- Debt Reduction: The principal amount of the Tranche A Term Loan was reduced by $20.0 million.
- Pricing Adjustment: The definition of "Applicable Rate" was amended, replacing the previous pricing table with a new tiered structure for Eurodollar Rate Loans, Base Rate Loans, and Commitment Fees.
- Facility Replacement: The Amendment replaces the existing Revolving Facility and Tranche A Term Loan with new facilities under the same names but with updated terms.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the summary of terms is not complete and is qualified by reference to the full Amendment attached as Exhibit 10. No specific forward-looking guidance, outlook, or management commentary regarding future operations is included in this text.
Risks and Contingencies: The cost of borrowing is now contingent upon the Company's Consolidated Leverage Ratio. Higher leverage ratios result in increased interest rates and commitment fees.
Important Facts for Investor Verification
- Verify the Company's current Consolidated Leverage Ratio to determine the applicable interest rate tier under the new agreement.
- Confirm the exact outstanding principal balance of the Tranche A Term Loan to ensure it aligns with the reduced $380.0 million cap.
- Review the full text of the Third Refinancing Facilities Amendment (Exhibit 10) for covenants and conditions not summarized in this 8-K.
- Check subsequent filings for any drawdowns on the $500.0 million Revolving Facility.